\
Sutent® 消定®

Sutent® 消定® 是一種美國食品藥品監督管理局認可及獲英國NICE指引推薦的口服標靶藥物1,2。在本港已被關愛基金納入為針對兩種病症的受資助藥物,協助有需要人士踏上治療成功之路3。
參考資料:
- Sutent® (sunitinib malate) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version May 2015.
- National Institute for Health and Clinical Excellence. NICE technology appraisal guidance 169. March 2009.
- Items Supported by the Samaritan Fund and Community Care Fund Medical Assistance Programme. Hong Kong Hospital Authority. Accessed on 6 June 2019. Available at https://www.ha.org.hk/visitor/ha_visitor_index.asp?content_id=208076#.
[PP-CPF-HKG-0070] SEP 2019

Therapeutic Area Sub Category: